Cita APA

Assenat, E., Desseigne, F., Thezenas, S., Viret, F., Mineur, L., Kramar, A., . . . Ychou, M. (2011). Cetuximab Plus FOLFIRINOX (ERBIRINOX) as First-Line Treatment for Unresectable Metastatic Colorectal Cancer: A Phase II Trial. AlphaMed Press.

Chicago Style Citation

Assenat, Eric, et al. Cetuximab Plus FOLFIRINOX (ERBIRINOX) As First-Line Treatment for Unresectable Metastatic Colorectal Cancer: A Phase II Trial. AlphaMed Press, 2011.

Cita MLA

Assenat, Eric, et al. Cetuximab Plus FOLFIRINOX (ERBIRINOX) As First-Line Treatment for Unresectable Metastatic Colorectal Cancer: A Phase II Trial. AlphaMed Press, 2011.